Compounds > cysteine

cysteine and ER-Negative PR-Negative HER2-Negative Breast Cancer

cysteine has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Akaike, T; Balog, N; Børresen Dale, AL; Csuka, O; Czikora, Á; Ditrói, T; Engebraten, O; Erdélyi, K; Hajdú, D; Ida, T; Johansson, HJ; Kásler, M; Lehtiö, J; Mátrai, Z; Nagy, P; Olasz, J; Silwal-Pandit, L; Tóvári, J; Uchida, K1
Kong, CC; Liu, XD; Song, CY; Tian, X1
Aguilar-Lemarroy, A; Bravo-Cuellar, A; Haramati, J; Hernández-Flores, G; Jave-Suárez, LF; Ortiz-Lazareno, PC; Rosas-González, VC; Solorzano-Ibarra, F; Téllez-Bañuelos, MC1
Alothaim, T; Charbonneau, M; Tang, X1
Backus, KM; Briggs, KJ; Cao, S; Clardy, J; Cravatt, BF; Gerfen, GJ; Kaelin, WG; Koivunen, P; Olenchock, BA; Patel, H; Richardson, AL; Signoretti, S; Witkiewicz, AK; Zhang, Q1
Chang, JT; Chi, JT; Ding, CK; George, D; Hsu, DS; McDonnell, DP; Sjol, J; Spasojevic, I; Tang, X; Wardell, S; Wu, J1

Other Studies

6 other study(ies) available for cysteine and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.
    Proceedings of the National Academy of Sciences of the United States of America, 2021, 11-09, Volume: 118, Issue:45

    Topics: Animals; Cohort Studies; Cystathionine beta-Synthase; Cysteine; Disease Progression; Female; Ferroptosis; Humans; Mice, SCID; Neovascularization, Pathologic; Oxidative Stress; Sulfides; Triple Negative Breast Neoplasms

2021
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway.
    Chinese journal of integrative medicine, 2022, Volume: 28, Issue:10

    Topics: Antioxidants; Apoptosis; Bufanolides; Caspase 3; Cell Line; Cell Line, Tumor; Cysteine; Docetaxel; Doxorubicin; Fluorescein-5-isothiocyanate; Humans; Necroptosis; Propidium; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Triple Negative Breast Neoplasms; Tumor Necrosis Factor-alpha

2022
Differential effects of alliin and allicin on apoptosis and senescence in luminal A and triple-negative breast cancer: Caspase, ΔΨm, and pro-apoptotic gene involvement.
    Fundamental & clinical pharmacology, 2020, Volume: 34, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cysteine; Disulfides; Female; Flow Cytometry; Garlic; Humans; Phytotherapy; Sulfinic Acids; Triple Negative Breast Neoplasms

2020
HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.
    Scientific reports, 2021, 05-26, Volume: 11, Issue:1

    Topics: Anilides; Carbamates; Cell Death; Cell Line, Tumor; Cysteine; Enzyme Activation; Epithelial Cells; Female; Gene Knockout Techniques; HEK293 Cells; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Homeostasis; Humans; Hydroxamic Acids; Indoles; Neoplasm Proteins; Oxazoles; Piperazines; Protein Kinase C; Small Molecule Libraries; Transcription, Genetic; Transcriptome; Triple Negative Breast Neoplasms; Zinc

2021
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.
    Cell, 2016, Jun-30, Volume: 166, Issue:1

    Topics: Amino Acid Transport System y+; Animals; Breast Neoplasms; Cysteine; Glutamic Acid; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; MCF-7 Cells; Mice; Paracrine Communication; Triple Negative Breast Neoplasms

2016
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling.
    Oncogene, 2017, 07-27, Volume: 36, Issue:30

    Topics: Cysteine; Epithelial-Mesenchymal Transition; Female; Humans; Necrosis; Phenotype; Signal Transduction; Triple Negative Breast Neoplasms

2017